{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:49:19Z","timestamp":1792194559863,"version":"4.4.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.1001\/jamaoncol.2021.5771","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T17:53:14Z","timestamp":1638467594000},"page":"281","source":"Crossref","is-referenced-by-count":74,"title":["Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer"],"prefix":"10.1001","volume":"8","author":[{"given":"Julie Tsu-Yu","family":"Wu","sequence":"first","affiliation":[{"name":"VA Palo Alto Healthcare System, Palo Alto, California"},{"name":"Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"La","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program, VA Boston Healthcare System, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Westyn","family":"Branch-Elliman","sequence":"additional","affiliation":[{"name":"VA Boston Healthcare System, Section of Infectious Diseases, Boston, Massachusetts"},{"name":"VA Boston Center for Healthcare Organization and Implementation Research (CHOIR), Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linden B.","family":"Huhmann","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program, VA Boston Healthcare System, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer S.","family":"Han","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Parmigiani","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts"},{"name":"Harvard School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Tuck","sequence":"additional","affiliation":[{"name":"VA Boston Healthcare System, Hematology\/Oncology Service, Boston, Massachusetts"},{"name":"Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary T.","family":"Brophy","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program, VA Boston Healthcare System, Boston, Massachusetts"},{"name":"VA Boston Healthcare System, Hematology\/Oncology Service, Boston, Massachusetts"},{"name":"Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhan V.","family":"Do","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program, VA Boston Healthcare System, Boston, Massachusetts"},{"name":"Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Y.","family":"Lin","sequence":"additional","affiliation":[{"name":"VA Palo Alto Healthcare System, Palo Alto, California"},{"name":"Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil C.","family":"Munshi","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts"},{"name":"VA Boston Healthcare System, Hematology\/Oncology Service, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael R.","family":"Fillmore","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program, VA Boston Healthcare System, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10241","key":"cbr210016r1","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"issue":"10241","key":"cbr210016r2","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","article-title":"COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.","volume":"395","author":"Lee","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"cbr210016r3","doi-asserted-by":"publisher","first-page":"e377","DOI":"10.1200\/OP.20.00790","article-title":"Changes in cancer management due to COVID-19 illness in patients with cancer in northern California.","volume":"17","author":"Wu","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"6","key":"cbr210016r4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/jnci\/djaa159","article-title":"Prevalence and outcome of COVID-19 infection in cancer patients: a national Veterans Affairs study.","volume":"113","author":"Fillmore","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"27","key":"cbr210016r5","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine.","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"cbr210016r6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"26","key":"cbr210016r7","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1182\/blood.2021011904","article-title":"Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.","volume":"137","author":"Terpos","year":"2021","journal-title":"Blood"},{"issue":"23","key":"cbr210016r8","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1182\/blood.2021011568","article-title":"Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.","volume":"137","author":"Herishanu","year":"2021","journal-title":"Blood"},{"issue":"6","key":"cbr210016r9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1470-2045(21)00213-8","article-title":"Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.","volume":"22","author":"Monin","year":"2021","journal-title":"Lancet Oncol"},{"issue":"8","key":"cbr210016r10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.ccell.2021.06.002","article-title":"Seroconversion rates following COVID-19 vaccination among patients with cancer.","volume":"39","author":"Thakkar","year":"2021","journal-title":"Cancer Cell"},{"issue":"15","key":"cbr210016r11","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting.","volume":"384","author":"Dagan","year":"2021","journal-title":"N Engl J Med"},{"issue":"n1088","key":"cbr210016r12","doi-asserted-by":"crossref","first-page":"n1088","DOI":"10.1136\/bmj.n1088","article-title":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on COVID-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.","volume":"373","author":"Lopez Bernal","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"cbr210016r13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccell.2021.01.001","article-title":"Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients.","volume":"39","author":"Abdul-Jawad","year":"2021","journal-title":"Cancer Cell"},{"issue":"8","key":"cbr210016r14","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/jamaoncol.2021.2155","article-title":"Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer.","volume":"7","author":"Massarweh","year":"2021","journal-title":"JAMA Oncol"},{"issue":"7","key":"cbr210016r15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1056\/NEJMc2108861","article-title":"Three doses of an mRNA COVID-19 vaccine in solid-organ transplant recipients.","volume":"385","author":"Kamar","year":"2021","journal-title":"N Engl J Med"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2786477\/jamaoncology_wu_2021_br_210016_1644950711.36636.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T16:08:28Z","timestamp":1645114108000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2786477"}},"subtitle":["A US Nationwide Veterans Affairs Study"],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2021.5771","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}